Condition

Chronic Spontaneous Urticaria (CSU) clinical trials and research

• 7Clinical trials
• 8Countries

Newest Chronic Spontaneous Urticaria (CSU) clinical trials

All recruiting trials (7)

• THB335 in adults with chronic spontaneous urticaria (CSU)

  A 12‑week study will test two doses of THB335 versus placebo in adults with CSU still having hives despite second‑generation antihistamines.

  Recruiting at 15 sites Phase 2 Calixis Inc. · Pasadena, California and 14 other locations · NCT07766499

• Switching to Omlyclo® (omalizumab biosimilar) for adults with chronic spontaneous urticaria or severe allergic asthma

  This will try switching adults who are stable on reference omalizumab to the biosimilar Omlyclo® to see if disease control and patient satisfaction stay the same over 12 months.

  Recruiting Celltrion HealthCare France · Montpellier · NCT07425639

• Lesigercept for adults with chronic spontaneous urticaria not controlled by H1-antihistamines

  This trial tests whether lesigercept, given every four weeks, can reduce symptoms in adults whose chronic spontaneous urticaria is not controlled by second-generation H1-antihistamines.

  Recruiting at 3 sites Phase 2 Yuhan Corporation · Sofia, Sofia and 29 other locations · NCT07415551

• ICP-332 for adults with moderate to severe chronic spontaneous urticaria not controlled by antihistamines

  This study tests whether ICP-332 tablets can reduce hives and itching in adults (18–75) with moderate to severe chronic spontaneous urticaria that is not controlled by second-generation H1-antihistamines.

  Recruiting Phase 2/3 Beijing InnoCare Pharma Tech Co., Ltd. · Bengbu, Anhui and 29 other locations · NCT07378527

• Different forms of IgE in health and disease.

  We will test whether different forms of IgE in the blood differ between healthy adults and people with allergies, chronic spontaneous urticaria, recent anaphylaxis, mastocytosis, hereditary alpha tryptasemia, X‑linked agammaglobulinemia, or those undergoing venom/medication desensitization.

  Recruiting KU Leuven · Leuven, Vlaams-Brabant · NCT07328178

• CM512 injection for adults with chronic spontaneous urticaria

  This study will test whether injections of CM512 reduce hives and itching in adults with chronic spontaneous urticaria who still have symptoms despite second-generation H1‑antihistamines.

  Recruiting Phase 2 Keymed Biosciences Co.Ltd · Tianjin, Tianjin Municipality · NCT07166211

• SKINERGY: deep biomarker profiling of immune-driven skin diseases in dermatology clinics

  This project will test whether detailed blood, tissue, imaging, and patient-reported biomarker profiles in adults with several immune-related skin conditions can find patterns that distinguish disease types and predict who responds to treatment.

  Recruiting Leiden University Medical Center · Nijmegen, Gelderland and 7 other locations · NCT07021495

Related topics

Quick answers

How many Chronic Spontaneous Urticaria (CSU) clinical trials are recruiting right now?

7, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 8 countries. The most sites are in China (3 trials), Netherlands (1 trial), United States (1 trial), France (1 trial), Belgium (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 3, Phase 2/3: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →